Monte Rosa Therapeutics, Inc. Annual Depreciation in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Monte Rosa Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2020 to 2023.
  • Monte Rosa Therapeutics, Inc. Depreciation for the quarter ending September 30, 2024 was $2.1M, a 14.7% increase year-over-year.
  • Monte Rosa Therapeutics, Inc. Depreciation for the twelve months ending September 30, 2024 was $7.91M, a 45.2% increase year-over-year.
  • Monte Rosa Therapeutics, Inc. annual Depreciation for 2023 was $6.22M, a 66.1% increase from 2022.
  • Monte Rosa Therapeutics, Inc. annual Depreciation for 2022 was $3.75M, a 75.7% increase from 2021.
  • Monte Rosa Therapeutics, Inc. annual Depreciation for 2021 was $2.13M, a 297% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $6.22M +$2.48M +66.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 $3.75M +$1.61M +75.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 $2.13M +$1.6M +297% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 $537K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.